“…However, despite a high pharmacological activity, the effectiveness of SFN is limited by its relatively low bioavailability, which is related to its low aqueous solubility . In this respect, porous nanomaterials have recently demonstrated a significant impact on enhancing the solubility of poorly water-soluble drugs by confining them in their amorphous state. , Among the large variety of available porous nanostructures, mesoporous silica nanoparticles (MSNs) have spearheaded the field of solid nanocarriers due to their biodegradability, the feasibility of surface modification, tunable nanoscale size, controllable shape and pore size, large pore volume and surface area, as well as high surface-to-volume ratio. , In addition to rendering enhancement of drug solubility, bioavailability, and antitumor activity, MSNs can be used for the development of theranostics or multitherapeutic nanosystems. − Nonetheless, several bottlenecks, such as high burst release and rapid aggregation limit the widespread application of mesoporous materials in nanomedicine. − In addition, low cellular association, internalization, and subsequent incapacity for the intracellular endosomal escape might reduce their therapeutic efficiency. , Utilization of gatekeepers, which block the MSN pores upon drug loading, is a promising approach to inhibit the undesired release and improve cellular internalization and intracellular drug delivery . Inorganic nanoparticles (NPs), such as gold NPs and superparamagnetic iron oxide NPs with small size diameters, have been used to cap pores of nanostructures, endowing nanocomposites with dual functionality. , In addition to these nanomaterials, cerium oxide NPs (CNPs) have drawn attention due to their high biocompatibility and potential therapeutic functionalities, such as anticancer effects, as well as neuroprotective, cardioprotective, and anti-inflammatory potentials. − In the cancer microenvironment, CNPs can create reactive oxygen species (ROS) in cancer cells, resulting in apoptosis, while, at the same time, CNPs have the capability of protecting healthy cells from the degenerative effect of ROS production .…”